Figure 2

Serial comparison of (a) SBP, (b) DBP, (c) eGFR and (d) LDL between the rituximab group and the matched controls. *P < 0.05, DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; LDL, low density lipoprotein; SBP, systolic blood pressure.